EUVIMEDEUVIMED entdecken
Crossref

Prophylactic use of granulocyte colony-stimulating factor in breast cancer chemotherapy in china: A retrospective observational study

Lilian Hu

Pakistan Journal of Pharmaceutical Sciences · 17.11.2026

DOI: 10.36721/pjps/2026.40.16111.1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pakistan Journal of Pharmaceutical Sciences, online erschienen am 17.11.2026. Verfasst von Lilian Hu. Die Arbeit nennt 18 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Febrile neutropenia (FN) is a serious complication of myelosuppressive chemotherapy. Clinical practice guidelines recommend risk-stratified prophylactic G-CSF therapy, which is indicated primarily for patients with a high risk of febrile neutropenia (FN >20%).Although G-CSF is widely used in clinical practice in China, it remains unclear whether this use aligns with guideline-recommended risk stratification, as few real-world studies have evaluated adherence.

Objectives

This study aimed to evaluate the appropriateness of prophylactic G-CSF use in hospitalized breast cancer patients and identify the gap between clinical practice and current guidelines.

Methods

In this single-center, retrospective observational study, we evaluated the prophylactic use of G-CSF according to FN risk category among breast cancer patients scheduled to receive myelosuppressive chemotherapy in hospitalized patients in China between January 2019 and December 2021.

Results

A total of 4,181 chemotherapy cycles from 630 breast cancer patients were documented. The overall rate of prophylactic G-CSF use was 53.1%. Among these, 1,963 cycles (46.9%) involved inappropriate prophylactic use, including 1,836 cycles (43.9%) with underuse, 101 cycles (2.4%) with overuse and 26 cycles (0.6%) with non-standard use.

Conclusion

This study reveals substantial inappropriate use of prophylactic G-CSF in Chinese breast cancer patients, primarily characterized by underuse in guideline-indicated scenarios.

Zitieren

APA

Hu, L. (2026). Prophylactic use of granulocyte colony-stimulating factor in breast cancer chemotherapy in china: A retrospective observational study. Pakistan Journal of Pharmaceutical Sciences. https://doi.org/10.36721/pjps/2026.40.16111.1

Vancouver

Hu L. Prophylactic use of granulocyte colony-stimulating factor in breast cancer chemotherapy in china: A retrospective observational study. Pakistan Journal of Pharmaceutical Sciences. 2026. doi:10.36721/pjps/2026.40.16111.1

BibTeX
@article{Hu2026,
  author = {Hu, Lilian},
  title = {Prophylactic use of granulocyte colony-stimulating factor in breast cancer chemotherapy in china: A retrospective observational study},
  journal = {Pakistan Journal of Pharmaceutical Sciences},
  year = {2026},
  doi = {10.36721/pjps/2026.40.16111.1}
}
Kostenlos starten →